EligibleTrials

Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

Recruiting · NCT07207122 · Interventional (participants receive a specific treatment) · Lead sponsor: Sanmai Technologies PBC dba Sanmai

View the official record on ClinicalTrials.gov →
Parkinson's disease

Interventions studied

Gen0Bh Transcranial Focused Ultrasound System (Active)Gen0Bh Transcranial Focused Ultrasound System (Sham)

What this trial is about

This is a pilot randomized, sham-controlled, double-blind, multi-center study evaluating the safety and preliminary effectiveness of the Gen0Bh Transcranial Focused Ultrasound System for the treatment of motor symptoms in individuals with idiopathic Parkinson's disease.

Who can take part

Age range
22 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

4 locations listed across 4 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.